#London #United Kingdom #medical cannabis #Curaleaf International #Jupiter Research

Curaleaf International and Jupiter Research Secure EU Certification for Revolutionary Medical Device

In an era where innovation in healthcare is paramount, Curaleaf International, a subsidiary of Curaleaf Holdings, has made a significant leap forward alongside Jupiter Research LLC, a branch of TILT Holdings Inc. Their recent achievement—securing EU medical device certification for Europe’s first handheld liquid inhalation device—marks a pivotal moment in the landscape of medical cannabis delivery.

Leading the Way in Medical Cannabis Delivery

The handheld device, developed to enable precise administration of medical cannabis, is now classified as a Class IIa medical device under EU regulations (Regulation (EU) 2017/745). This certification signifies that the device has met strict regulatory standards concerning its safety, quality, and efficacy. Its innovative design features a magnetic snap-in cartridge that houses the cannabis liquid and a rechargeable power supply that ensures consistent and controlled cannabinoid delivery with every use.

By completing a comprehensive technical file, including EU Declaration of Conformity, both companies have validated their commitment to quality and safety. Approved by a recognized EU Notified Body, this device not only fulfills regulatory requirements but also enhances patient experience through its user-friendly design.

Expansion and Global Reach

The securement of this certification is set to expedite the product's rollout across multiple global markets. Healthcare professionals can soon recommend this groundbreaking device to patients in various countries, including those in Europe, the UK, Canada, and Australasia. This broad accessibility opens new possibilities for patients seeking effective cannabis-based treatments, ultimately promising more personalized healthcare solutions.

Curaleaf's Chairman and CEO, Boris Jordan, emphasized the importance of this milestone, stating, “Achieving EU medical certification is more than a regulatory milestone—it’s a signal that medical cannabis innovation is moving into the mainstream of global healthcare.” His remarks underscore the pivotal role that such advancements play in integrating cannabis solutions into conventional medical practices.

A Strong Partnership

Tim Conder, the CEO of TILT, echoed this sentiment, noting, “This partnership has been a natural extension of our long-standing collaboration in the US. By delivering industry-leading, user-friendly solutions, our collaboration exemplifies how technology can revolutionize healthcare.” Both leaders foresee the device setting a new standard in the industry, bridging the gap between innovation and patient needs.

Commitment to Quality and Safety

Curaleaf International remains dedicated to advancing patient access to high-quality cannabis treatments. With a robust network of facilities, including a clinic and pharmacy in the UK and EU-GMP certified processing facilities in Portugal and Spain, Curaleaf is positioned as a leader in shaping the future of cannabis.

The company’s infrastructure allows it to maintain rigorous quality standards throughout production, fostering excellence in cannabis research, cultivation, and distribution across Europe and beyond.

About Curaleaf International and TILT Holdings

Curaleaf International operates by embracing research and product excellence, leveraging cutting-edge technology to improve patient care. TILT Holdings, which owns Jupiter Research, emphasizes both technology and hardware in the cannabis sector, demonstrating a multifaceted approach to enhancing healthcare delivery.

With the certification of this handheld device, both companies not only highlight the importance of innovation in the cannabis space but also set the stage for a future where personalized and effective treatments are more accessible to patients in need. As Curaleaf International continues its mission, healthcare professionals and patients alike look forward to the integration of this revolutionary device into everyday medical practice.